Does estrogen stimulate osteoblast function in postmenopausal women?

Bone

Volumn 24, Issue 2, 1999, Pages 121-124

  Tobias, J H ^a   Compston, J E ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Estrogen; Osteoblasts; Postmenopausal woman

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE;

ARTICLE; CELL FUNCTION; DOG; DRUG IMPLANT; FEMALE; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOBLAST; POSTMENOPAUSE;

AGED; ANIMALS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0032908396     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00156-2     Document Type: Article

References (48)

1. Aitken J.M., Hart D.M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 3:1973;515-518.
2. Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., Bauer D.C., Genant H.K., Haskell W.L., Marcus R., Ott S.M., Torner J.C., Quandt S.A., Reiss T.F., Ensrud K.E. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 348:1997;1535-1541.
3. Bradbeer J.N., Arlot M.E., Meunier P.J., Reeve J. Treatment of osteoporosis with parathyroid hormone (hPTH 1-34) and oestrogen Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased packets of newly formed bone . Clin Endocrinol. 37:1992;282-289.
4. Cheng M.Z., Zaman G., Rawlinson S.C.F., Suswillo F.L., Lanyon L. Mechanical loading and sex hormone interactions in organ cultures of rat ulna. J Bone Miner Res. 11:1996;502-511.
5. Chow J., Tobias J.H., Colston K.W., Chambers T.J. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest. 89:1992;74-78.
6. Christiansen C., Christiansen M.S., Larsen N.-E., Transbol I. Pathophysiological mechanism of estrogen effect on bone metabolism Dose-response relationship in early postmenopausal women . J Clin Endocrinol Metab. 55:1982;1124-1130.
7. Christiansen C., Riis B.J. 17β-estradiol and continuous norethisterone A unique treatment for established osteoporosis in elderly women . J Clin Endocrinol Metab. 71:1990;836-841.
8. Compston, J. E. 1996. Mechanisms of drug-induced effects on bone. In: Compston, J. E., Ed. Osteoporosis. New perspectives on causes, prevention and treatment. London: Royal College of Physicians; 83-95.
9. Cummings S., Black D., Vogt T. Changes in BMD substantially underestimate the anti-fracture effects of alendronate and other antiresorptive drugs. J Bone Miner Res. 11:(Suppl. 1):1996;S102.
10. Dhuper S., Warren M.P., Brooks-Gunn J., Fox R. Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab. 71:1990;1083-1088.
11. Dobnig H., Turner R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 136:1995;3632-3638.
12. Edwards M.W., Bain S.D., Bailey M.C., Lantry M.M., Howard G.A. 17β estradiol stimulation of endosteal bone formation in the ovariectomised mouse An animal model for the evaluation of bone-targeted estrogens . Bone. 13:1992;29-34.
13. Eiken P., Nielsen S.P., Kolthoff N.K. Effects on bone mass after eight years of hormone replacement therapy. Br J Obstet Gynaecol. 104:1997;702-707.
14. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:1988;84-86.
15. Ettinger B., Genant H.K., Cann C.E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Int Med. 102:1985;319-324.
16. Ettinger B., Genant H.K., Cann C.E. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen and calcium. Ann Int Med. 106:1987;40-45.
17. Fuleihan G.E., Brown E.M., Curtis K., Berger M.J., Berger B.M., Gleason R., LeBoff M.S. Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Intern Med. 152:1992;1904-1909.
18. Garnett T., Studd J., Watson N., Savvas M. A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density. Obstet Gynaecol. 78:1991;1002-1007.
19. Hasling C., Eriksen E.F., Melkko J., Risteli L., Charles P., Mosekilde L., Risteli J. Effects of combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis. J Bone Miner Res. 6:1991;1295-1300.
20. Hillard T.C., Whitcroft S.J., Marsh M.S., Ellerington M.C., Lees B., Whitehead M.I., Stevenson J.C. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteopor Int. 4:1994;341-348.
21. Hodsman A.B., Steer B.M. Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis Evidence for de novo bone formation on quiescent cancellous surfaces . Bone. 14:1993;523-527.
22. Khastgir G., Studd J., Holland N., Alaghband-Zadeh J., Fox S., Chow J. Histomorphometric changes in bone after long-term percutaneous oestrogen replacement in older postmenopausal women with low bone mineral density. Ring E.F.J., Elvins D.M., Bhalla A.K. Bath conference on osteoporosis and bone mineral measurement. 1998;112 British Institute of Radiology, Bath, UK.
23. Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Gallegos A., Korc M., Greene G.L., O'Malley B.W., Haussler M.R. Estrogenic binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science. 241:1988;81-83.
24. Liberman U.A., Weiss S.R., Broll J., Minne H.W., Quan H., Bell N.H., Rodriquez-Portales J., Downs R.W. Jr, Dequeker J., Favus M., Seeman E., Recker R.R., Capizzi T., Santora A.C., Lombardi A., Shah R.V., Hirsch L.J., Karpf D.B. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 333:1995;1437-1443.
25. Lindsay R., Hart D.M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet. ii:1980;1151-1153.
26. Lindsay R., Tohme J.F. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynaecol. 76:1990;290-295.
27. Lufkin E.G., Wahner H.W., O'Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1992;1-9.
28. Malluche H.H., Faugere M.-C., Rush M., Friedler R.M. Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental Beagle dogs. Endocrinology. 119:1986;2649-2654.
29. Meunier P.J., Boivin G. Bone mineral density reflects bone mass but also the degree of mineralisation of bone Therapeutic implications . Bone. 21:1997;373-377.
30. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:1995;3689-3698.
31. Munk-Jensen N., Pors Nielsen S., Obel E.B., Eriksen P.B. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen A double-blind placebo controlled study . Br Med J. 296:1988;1150-1152.
32. Parfitt A.M. Quantum concept of bone remodelling and turnover Implications for the pathogenesis of osteoporosis . Calcif Tissue Int. 28:1979;1-5.
33. Raisz L., Wiita B., Artis A., Bowen A., Schwartz S., Trahiotos M., Shoukri K., Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:1996;37-43.
34. Riggs B.L., Jowsey J., Goldsmith R.S., Kelly P.J. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest. 51:1972;1659-1663.
35. Ryde S.J.S., Bowen-Simpkins K., Bowen-Simpkins P., Evans W.D., Morgan W.D., Compston J.E. The effect of oestradiol implants on regional and total bone mass A three year longitudinal study . Clin Endocrinol. 40:1994;33-38.
36. Siddhanti S., Quarles L. Molecular to pharmacological control of osteoblast proliferation and differentiation. J Cell Biochem. 55:1994;310-320.
37. Smith E.C., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1994;1056-1061.
38. Steel S.A., Howey S., Purdie D.W. A 5-year prospective study of BMD behaviour in HRT treated and untreated perimenopausal women. Ring E.F.J., Elvins D.M., Bhalla A.K. Bath Conference on Osteoporosis and Bone Mineral Measurement. 1996;130 British Institute of Radiology, Bath, UK.
39. Steiniche T., Eriksen E.F., Kudsk H., Mosekilde L., Melsen F. Reconstruction of the formative site in trabecular bone by a new, quick and easy method. Bone. 13:1992;147-152.
40. Steiniche T., Hasling C., Charles P., Erikesen E.F., Mosekilde L., Melsen F. A randomised study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone. 10:1989;313-320.
41. Stepan J.J., Presl J., Broulik P., Pacovsky V. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and primary hyperparathyroidism. J Clin Endocrinol Metab. 64:1987;1079-1084.
42. Takano-Yamamoto T., Rodan G.A. Direct effects of 17β-estradiol on trabecular bone in ovariectomised rats. Proc Natl Acad Sci USA. 87:1990;2172-2176.
43. Turner C.H. Homeostatic control of bone structure An application of feedback theory . Bone. 12:1991;203-217.
44. Turner R.T., Colvard D.S., Spelsberg T.C. Estrogen inhibition of periosteal bone formation in rat long bones Down-regulation of gene expression for bone matrix proteins . Endocrinology. 127:1990;1346-1351.
45. Vedi S., Compston J.E. The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone. 19:1996;535-539.
46. Vedi S., Purdie D.W., Bord S., Ballard P., Cooper A.C., Compston J.E. Anabolic skeletal effects of long-term, high-dose oestrogen therapy in postmenopausal women. Ring E.F.J., Elvins D.M., Bhalla A.K. Bath Conference on Osteoporosis and Bone Mineral Measurement. 1998;112 British Institute of Radiology, Bath, UK.
47. Wahab M., Ballard P., Purdie D.W., Cooper A., Willson J.C. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynaecol. 104:1997;728-731.
48. 2 in young rats increases the osteogenic capacity of bone marrow. Bone. 20:1997;521-526.